ArticleThe Journal of urology2019
Re: Comparative Safety of Pioglitazone versus Clinically Meaningful Treatment Alternatives Concerning the Risk of Bladder Cancer in Older US Adults with Type 2 Diabetes.
Tomas L GrieblingPubMed ↗Publisher ↗
No numbers read from the abstract.